The present disclosure relates to fluid absorbers, along with a process for making the fluid absorber, which may be used, for example, by Parkinson's disease patients. The fluid absorber may include individual units that are folded into each other. The fluid absorber may be folded into a rectangle or square. The fluid absorber is then placed into an antimicrobial solution, and left to dry. In this way, a fluid absorber may have antimicrobial properties that reduce or eliminate tooth decay associated with hypersalivation. The fluid absorber is then placed inside the patient's mouth where it absorbs saliva until it becomes saturated. The fluid absorber may then be disposed.

A medical device includes a handle, an end cap, and a patch. The handle includes a movable body and a stationary body. The movable body includes an actuation member. The end cap is configured to be coupled to a distal end of a scope. The patch is movable relative to the end cap. The patch is coupled to the movable body via one or more control elements such that movement of the movable body extends the patch from the end cap. The patch is further coupled to the actuation member via one or more actuation elements such that movement of the actuation member extends, bows, or bends the one or more actuation elements to at least partially deploy the patch.

This invention relates to a multi-layer wound site dressing specifically designed to treat chronic wounds and simultaneously block external pathogens from infecting the wound site from the environment. The said wound dressing comprises five layers; each layer performs a specific functionality in healing and protecting the wound site. The said layers of wound care dressing comprise (i) a permeable non-adherent woven or non-woven membrane in contact with wound site, (ii) a nanofibrous composite layer made of superabsorbent, activated carbon and a polymer (iii) a hydrophobic insulating membrane which is permeable to air with an adhesive edge, (iv) a nanofibrous membrane made of polymer and activated carbon hosting functional germicidal ions, and (v) an air permeable non-woven membrane with adhesive edge. The said layers are compounded by pressing and coating to make a comprehensive multi-layer wound care dressing product.

A sanitary aid with antibacterial effect for stabilization of physiological balance in vaginal environment and/or external genitalia is made by a backsheet impermeable layer, absorbent core formed by a mixture of absorbent and/or superabsorbent and a topsheet layer from woven or non-woven textile or from cellulose. The sanitary aid contains an effective component on the basis of at least one reactive form of oxygen, which is encapsulated by an encapsulation agent, where the effective substance is arranged on the topsheet layer of the sanitary aid designated for the contact with body and/or in the absorbent core. The sanitary aid is adapted for gradual release of reactive forms of oxygen, particularly hydrogen peroxide after contact with liquid from the sanitary aid, which causes the prolongation of the effect of reactive forms of oxygen with substantial disinfection ability.

A tampon including a pledget, a wicking member disposed in direct contact with the pledget, and a withdrawal cord is disclosed. The wicking member is non-coaxially arranged with respect to the withdrawal cord.

A disposable device for absorbing urine and/or bodily fluids in the urethra having a cylindrical body having a top and bottom end. The body is made of absorbent material that expands upon contact with urine and bodily fluids and includes a string connected to the bottom end of the body for removing the device from the urethra. The device can include a vasodilator in or on a surface of the body and can be used to treat urinary incontinence and/or erectile dysfunction by inserting into the urethra and removing the device after it has been impregnated with fluid. The device can be included in a kit with a plunger for insertion.

The invention relates to porous absorbent Composite Material, which may be used e.g. in the form of a plug or tampon, for instance for controlling bleeding, wound closure, prevent tissue adhesion and/or support tissue regeneration. The invention provides a hydrophilic Self-Dispersive, fragmentable and Bio-Absorbable Porous Composite foams, suitable for packing antrum or other cavities of the body, comprising of composite of polymers, which polymer preferably comprises C(O)O; NH2/3+; OH; CH2OCH2C(O)O groups as functional or CHO (e.g. C2H4O; C6H10O5; C6H8O6); CHNO (e.g. C8H13NO5); OCC (e.g. O-CH2-CH2); C(O)N groups in the backbone of the polymers e.g. gelatin, chitosan, collagen, alginate, polyvinyl alcohol, polyethylene glycol, keratin, cellulose.

An absorbent article includes a body portion extending along a first axis and having a proximal end and a distal end spaced from the proximal end along the first axis. The absorbent article also includes a plurality of layers radially disposed about the body portion. Each layer includes one or more absorbent petals each extending along a petal axis. The petal axis of one of the petals of one of the layers is angularly offset to the petal axis of an adjacent petal of an adjacent layer. The one or more absorbent petals are movable between a compacted configuration and an expanded configuration. The one or more absorbent petals, when introduced to a fluid, is configured to absorb the fluid and transition from the compacted configuration to the expanded configuration. The absorbent article includes a string coupled to the body portion. The body portion and/or string includes hemp.

A medical device may comprise a handle, wherein the handle includes a movable body and a main body; a cap configured to be coupled to a distal end of a scope; a patch, wherein the patch is moveable relative to the cap; and a petal body. The patch may be removably coupled to the petal body. The medical device may further comprise an actuator body coupling the patch to the moveable body such that movement of the moveable body extends the patch from the cap. The petal body may be configured to transition between a closed configuration in which the patch is retracted, and an open configuration in which the patch is extended radially-outward from a central longitudinal axis of the scope.

A method, medicated feminine sanitary products and pharmaceutical compositions for reducing menstrual blood loss in a female are provided. The method includes administering a hemostatic agent on a medicated feminine sanitary product during menstrual bleeding, wherein the hemostatic agent is incorporated in the medicated feminine sanitary product as a pharmaceutically acceptable composition, wherein the hemostatic agent is -amino-caproic acid, wherein the feminine sanitary product includes an amount of -amino-caproic acid ranging from 100 mg to 500 mg.